Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × temsirolimus × 1 year × Clear all

Sponsor

Conditions

Neoplasms 4 Neoplasm Metastasis 3 Sarcoma 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 Recurrence 1 Pharyngeal Neoplasms 1 PRETEXT I Hepatoblastoma 1 Neurofibromatosis 2 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Mesothelial 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Erdheim-Chester Disease 1 Endometrial Adenocarcinoma 1 Endocrine Gland Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡